P. L. Perlman

894 total citations
30 papers, 527 citations indexed

About

P. L. Perlman is a scholar working on Molecular Biology, Genetics and Pharmacology. According to data from OpenAlex, P. L. Perlman has authored 30 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Genetics and 5 papers in Pharmacology. Recurrent topics in P. L. Perlman's work include Estrogen and related hormone effects (8 papers), Steroid Chemistry and Biochemistry (7 papers) and Analytical Chemistry and Chromatography (3 papers). P. L. Perlman is often cited by papers focused on Estrogen and related hormone effects (8 papers), Steroid Chemistry and Biochemistry (7 papers) and Analytical Chemistry and Chromatography (3 papers). P. L. Perlman collaborates with scholars based in United States. P. L. Perlman's co-authors include E. B. Hershberg, Hershel L. Herzog, Sibylle Tolksdorf, William Charney, Maurice M. Pechet, Janis Gabliks, E. C. Herrmann, Eugene P. Oliveto, Frank J. Villani and Thomas H. McGavack and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

P. L. Perlman

29 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. L. Perlman United States 12 238 84 77 66 62 30 527
Erwin Schwenk United States 16 320 1.3× 58 0.7× 95 1.2× 25 0.4× 49 0.8× 33 658
A. L. Beyler United States 14 207 0.9× 162 1.9× 165 2.1× 47 0.7× 138 2.2× 33 629
John J. Schneider United States 15 265 1.1× 194 2.3× 103 1.3× 66 1.0× 96 1.5× 34 620
Ron Filler United States 8 184 0.8× 71 0.8× 81 1.1× 63 1.0× 101 1.6× 12 444
Stanley C. Lyster United States 14 123 0.5× 85 1.0× 85 1.1× 36 0.5× 180 2.9× 30 481
Lennart Krabisch Sweden 11 136 0.6× 43 0.5× 59 0.8× 31 0.5× 21 0.3× 22 457
R.W. McGilvery United States 11 411 1.7× 133 1.6× 41 0.5× 13 0.2× 23 0.4× 13 746
R. O. Hurst Canada 12 366 1.5× 31 0.4× 56 0.7× 10 0.2× 53 0.9× 33 626
Elwood Largis United States 16 422 1.8× 93 1.1× 169 2.2× 51 0.8× 21 0.3× 30 977
G. O. Potts United States 17 252 1.1× 311 3.7× 187 2.4× 73 1.1× 317 5.1× 47 978

Countries citing papers authored by P. L. Perlman

Since Specialization
Citations

This map shows the geographic impact of P. L. Perlman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. L. Perlman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. L. Perlman more than expected).

Fields of papers citing papers by P. L. Perlman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. L. Perlman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. L. Perlman. The network helps show where P. L. Perlman may publish in the future.

Co-authorship network of co-authors of P. L. Perlman

This figure shows the co-authorship network connecting the top 25 collaborators of P. L. Perlman. A scholar is included among the top collaborators of P. L. Perlman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. L. Perlman. P. L. Perlman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Herzog, Hershel L., et al.. (1962). Microbiological transformation of steroids—X. Tetrahedron. 18(5). 581–589. 20 indexed citations
2.
Peckham, W. D., et al.. (1962). The distribution and excretion of radioactivity after administration of 35S-labeled perphenazine (Trilafon). Biochemical Pharmacology. 11(6). 417–422. 11 indexed citations
3.
Reimann, Hans, et al.. (1960). Halogenated Progesterones. I. 9α,11β-Dihaloprogesterones. Journal of the American Chemical Society. 82(9). 2308–2311. 5 indexed citations
4.
Robinson, C. H., et al.. (1960). 16,16-DIFLUOROESTRONE DERIVATIVES. A NEW SERIES OF CHOLESTEROL LOWERING AGENTS. Journal of the American Chemical Society. 82(19). 5256–5257. 5 indexed citations
5.
Herrmann, E. C., et al.. (1960). Agar Diffusion Method for Detection and Bioassay of Antiviral Antibiotics. Experimental Biology and Medicine. 103(3). 625–628. 73 indexed citations
6.
Herrmann, Ernest C., et al.. (1959). Action of anti-inflammatory agents on endotoxin-induced lung inflammation in mice. American Journal of Physiology-Legacy Content. 197(4). 803–807. 3 indexed citations
7.
Oliveto, Eugene P., Hershel L. Herzog, E. B. Hershberg, et al.. (1958). 16-ALKYLATED CORTICOIDS. III. 16β-METHYL-9α-FLUOROPREDNISOLONE 21-ACETATE. Journal of the American Chemical Society. 80(24). 6687–6688. 20 indexed citations
8.
Oliveto, Eugene P., et al.. (1958). 16-ALKYLATED CORTICOIDS. I. 16α-METHYL-PREDNISONE AND 16β-METHYLPREDNISONE1. Journal of the American Chemical Society. 80(16). 4428–4428. 23 indexed citations
9.
Oliveto, Eugene P., et al.. (1958). Notes - Attempts to Prepare New Progestational Agents: Synthesis and Biological Activity of 11β-Acyloxyprogesterones. The Journal of Organic Chemistry. 23(1). 121–123. 4 indexed citations
10.
Shapiro, Elliot L., E. B. Hershberg, William Charney, et al.. (1957). SOME NEW ACTIVE CORTICOSTEROIDS. Journal of the American Chemical Society. 79(2). 502–503. 9 indexed citations
11.
Hershberg, E. B., et al.. (1957). Long-acting Testosterone Esters. Some Considerations on their Biological Utilization1. Journal of the American Chemical Society. 79(16). 4472–4475. 14 indexed citations
12.
Perlman, P. L., et al.. (1956). Some Metabolic Effects of  1,4-pregnadiene-17 ,21-diol-3,11,20-trione (Meticorten) Administered Orally to Dogs. Experimental Biology and Medicine. 91(4). 551–554. 2 indexed citations
13.
Tolksdorf, Sibylle, et al.. (1956). Adrenocortical Properties of  1,4-pregnadiene-17 ,21-diol-3,11,20-trione (Meticorten) and  1,4-pregnadiene-11 ,17 ,21-triol-3,20-dione (Meticortelone).. Experimental Biology and Medicine. 92(1). 207–214. 8 indexed citations
14.
Perlman, P. L., et al.. (1955). Biological Properties of a Highly Purified Preparation of 17-Alpha Estradiol. Experimental Biology and Medicine. 88(1). 158–160. 2 indexed citations
15.
Perlman, P. L., et al.. (1955). Studies on the absorption and excretion of a new cholecystographic agent, teridax®. Journal of the American Pharmaceutical Association (Scientific ed ). 44(2). 69–74. 8 indexed citations
16.
Herzog, Hershel L., Sibylle Tolksdorf, William Charney, et al.. (1955). New Antiarthritic Steroids. Science. 121(3136). 176–176. 86 indexed citations
18.
Perlman, P. L., et al.. (1953). Further Studies on the Metabolic Disposition of Dormison (3-Methyl-Pentyne-ol-3) in Dogs and Man. Journal of the American Pharmaceutical Association (Scientific ed ). 42(12). 750–752. 11 indexed citations
19.
Perlman, P. L., et al.. (1952). The Metabolism of Dormison (3-Methyl-Pentyne-ol-3, Methyl Parafynol) and Methods for the Estimation of Dormison in Biological Material. Journal of the American Pharmaceutical Association (Scientific ed ). 41(1). 13–16. 13 indexed citations
20.
Perlman, P. L., et al.. (1951). A New Class of Hypnotics: Unsaturated Carbinols. Science. 114(2963). 384–385. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026